Citra-Lock 4% is recommended in the European Renal Best Practice Guidelines (ERBP) and the American Society of Diagnostic and Interventional Nephrology (ASDIN).
Citra locks have been extensively studied.
4% offers the best benefit/risk ratio.
Citra-Lock is effective in maintaining catheter patency.
Trisodium Citrate 4% (TSC) works as an anti-coagulant and decreases the incidence of infection.
Clinical advantage of Citra-Lock 4% (compared to heparine)
Increase Safety & Simplified handling
The Citra-Lock vial features a drip free Luer-Slip/Luer-Lock connector
Citra-Lock™ 4% 5ml vial
Boxes contain 20 x 5ml vials
Art. nr. :24060201
Citra-Gen products are part of international recommended guidelines of today, defined by clinicians. Citra-Gen presents its products worldwide through a global network of dedicated distributors. Therefore, Citra-Gen is able to offer a high level of support to local customers.
Effective range of biocompatible catheters, prepared for state of the art blood flows.— Citra-XS™ Catheters
Citra-Lock™ is recommended in the European Renal Best Practice Guidelines (ERBP) and the American Society of Diagnostic and Interventional Nephrology (ASDIN).— Citra-Lock™